[Skip to Navigation]
October 2, 2018

Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease

Author Affiliations
  • 1National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Bethesda, Maryland
JAMA. 2018;320(13):1315-1316. doi:10.1001/jama.2018.12852

Tuberculosis (TB) is the leading cause of infectious disease mortality and continues to be a major challenge to global health. Each day, roughly 5000 people die of TB disease, resulting in nearly 2 million deaths in 2016 alone.1 More than 1 billion people died from TB during the last 200 years, more deaths than from malaria, influenza, smallpox, HIV/AIDS, cholera, and plague combined.2 Recently, the global health community intensified efforts to end TB as a global health scourge. This momentum was manifested at the World Health Organization (WHO) Global Ministerial Conference on Ending TB in the Sustainable Development Era: A Multisectoral Response that took place in Moscow in November 2017 and will be on display at the United Nations General Assembly High-Level Meeting on Ending TB in September 2018.